🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06510842
Recruiting Not applicable

Lumbar Drainage of Intraventricular Hemorrhage

NCT06510842 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2025-01-16
Last updated
2026-01-28

Condition(s) studied

Intraventricular HemorrhageLumbar DrainageExternal Ventricular Drainage

Investigational drug(s) / intervention(s)

External drainage of intraventricular hemorrhage

External drainage of intraventricular hemorrhage: An EVD is required to be eligible for the DRAIN IVH study. Weaning from the EVD is at the discretion of the local investigators. Imaging is at discretion of local investigators. Use, timing and frequency of fibrinolysis via EVD is at local discretion, too.

Study summary

Intracerebral hemorrhage (ICH) is a debilitating and fatal disease, especially when the hemorrhage is also entering the cerebral ventricles leading to acute hydrocephalus. In these cases, patients need a drainage through external ventricular drains (EVD). In the longer term, patients often need a permanent ventriculoperitoneal (VP) shunt to avoid hydrocephalus. Here we hypothesize that the early insertion of a lumbar drainage in addition to the EVD could lead to better functional outcome and avoidance of VP shunting by drainage of the blood which promotes inflammatory and adverse effects in the subarachnoid space. For that we propose a multi-center randomized clinical trial to investigate the hypothesis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ICH with IVH (with hemorrhage in the 3rd and/or 4rth ventricle) with the need for EVD placement due to acute hydrocephalus * Age ≥ 18 y * Lumbar drain can be inserted within 72 h after symptom onset or patient last seen well Exclusion Criteria: * Premorbid mRS score \> 2 * Pregnancy * Life expectancy \<6 months * Patient/family/caregiver unwilling or unlikely to opt for at least two weeks of aggressive therapy prior to consideration of transition to comfort measures/discontinuation of life support measures. * Treating physicians deeming the prognosis as so grave that an aggressive therapy is not warranted. * Other clear contraindication for treatment with a lumbar drain

Primary outcome measure(s)

Trial sites (12)

FacilityCityRegionStatus
Department of Neurology, University Hospital Heidelberg Heidelberg Baden-Wurttemberg Recruiting
LMU München München Bavaria Recruiting
Augsburg University Hospital Augsburg Germany Recruiting
Charite Universitätsmedizin Berlin Berlin Germany Not Yet Recruiting
Düsseldorf Universitiy Hospital Düsseldorf Germany Recruiting
Frankfurt University Hospital Frankfurt Germany Not Yet Recruiting
Goettingen University Hospital Göttingen Germany Not Yet Recruiting
Augsburg University Hospital Department of Neurosurgery Heidelberg Germany Recruiting
Heidelberg University Hospital Department of Neurosurgery Heidelberg Germany Recruiting
Mainz University Hospital Mainz Germany Not Yet Recruiting
Mannheim University Hospital Mannheim Germany Recruiting
Osnabrück Clinic Osnabrück Germany Recruiting

More University Hospital Heidelberg trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06510842 on ClinicalTrials.gov ↗ ← All trials in Germany